Clinical Trial: A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Randomized, Double-blind Study of the Effect of Beta-lactam on Treatment Response in Patients Hospitalized With Bacterial Pneumonia
Brief Summary: This study will assess the efficacy and safety of intravenous beta-lactam, in comparison with ceftriaxone, in hospitalized patients with community-acquired pneumonia not caused by Legionella. The anticipated time on study treatment is 3-12 months and the target sample size is 100-500 individuals.
Detailed Summary:
Sponsor: Hoffmann-La Roche
Current Primary Outcome: Clinical cure rate\n\n [ Time Frame: End of study visit (7-10 days after end of treatment) ]
Original Primary Outcome:
Current Secondary Outcome: Adverse events, vital signs, laboratory parameters\n [ Time Frame: Throughout study ]
Original Secondary Outcome:
Information By: Hoffmann-La Roche
Dates:
Date Received: May 24, 2005
Date Started: March 2005
Date Completion:
Last Updated: November 1, 2016
Last Verified: November 2016